Academic journals

The American Journal of Managed Care® Welcomes Submissions for 11th Annual Health IT-Focused Issue

Monday, May 10, 2021 - 3:55pm

The final decision regarding a paper\'s acceptance will be made by Cross.

Key Points: 
  • The final decision regarding a paper\'s acceptance will be made by Cross.
  • High-quality papers not selected for this issue will be considered for one of the regular monthly issues of AJMC.\n"This annual special issue always profiles exciting research advancements in the use of health IT to support care delivery and population health," Cross said.
  • "\nFor more information about how to submit a manuscript, click here.\nThe American Journal of Managed Care (AJMC) is a multimedia,peer-reviewed, MEDLINE-indexed journal that keeps industry leaders on the forefront of health policy by sharing digital research relevant to industry decision-makers.
  • Other brands in theAJMCfamily includeThe American Journal of Accountable Careand Evidence-Based Oncology.

Aesthetic Medicine Market Revenue to Cross USD 29 Bn by 2027: Global Market Insights Inc.

Monday, May 10, 2021 - 10:00am

A high penetration rate in developing economies and awareness in developed markets has offered immense growth opportunities to the industry.

Key Points: 
  • A high penetration rate in developing economies and awareness in developed markets has offered immense growth opportunities to the industry.
  • Lockdown restrictions and limitations on non-essential practices in several countries has impacted the global growth.
  • Improvements and development in these devices by industry players has further led to greater adoption.\nFemale segment dominated more than 77% of the aesthetic medicine market share in 2020.
  • According to the International Society of Aesthetic Plastic Surgery, more than 9,000,000 procedures were performed in 2019 among women alone.

Feinstein Institutes Receives $3.7M NIH Support for Bioelectronic Medicine Research

Thursday, May 6, 2021 - 2:00pm

b'The Feinstein Institutes for Medical Research , the global scientific home of bioelectronic medicine , has been awarded a five-year grant totaling more than $3.7 million from the National Institutes of Health\xe2\x80\x99s (NIH) National Institute of General Medical Sciences (NIGMS) to support research in the molecular basis of bioelectronic medicine.

Key Points: 
  • b'The Feinstein Institutes for Medical Research , the global scientific home of bioelectronic medicine , has been awarded a five-year grant totaling more than $3.7 million from the National Institutes of Health\xe2\x80\x99s (NIH) National Institute of General Medical Sciences (NIGMS) to support research in the molecular basis of bioelectronic medicine.
  • View the full release here: https://www.businesswire.com/news/home/20210506005048/en/\nKevin J. Tracey, MD, president and CEO of the Feinstein Institutes.
  • (Credit: The Feinstein Institutes for Medical Research)\nBioelectronic medicine explores the use of electronic devices to treat disease and injury through the body\xe2\x80\x99s nervous system instead of pharmaceuticals.
  • Home to 50 research labs, 2,500 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine.

Dove Medical Press Appoints Dr. Edgar Alfonso Romero-Sandoval Deputy Editor-in-Chief of the Journal of Pain Research

Thursday, May 6, 2021 - 5:00am

b'NEW YORK, May 6, 2021 /PRNewswire-PRWeb/ -- Dove Medical Press is pleased to announce the appointment of Dr. Edgar Alfonso Romero-Sandoval , as the Deputy Editor-in-Chief of the Journal of Pain Research .

Key Points: 
  • b'NEW YORK, May 6, 2021 /PRNewswire-PRWeb/ -- Dove Medical Press is pleased to announce the appointment of Dr. Edgar Alfonso Romero-Sandoval , as the Deputy Editor-in-Chief of the Journal of Pain Research .
  • Professor Romero-Sandoval is currently Associate Professor in Anesthesiology at Wake Forest University School of Medicine, Winston Salem, NC (U.S.).
  • The Romero-Sandoval laboratory explores neuroimmune interactions in surgical and neuropathic pain and neuropathies induced by diabetes or chemotherapy.
  • "\nThe Journal of Pain Research is an international, peer-reviewed, open access, online journal that welcomes laboratory and clinical findings in the fields of pain research and the prevention and management of pain.

Perspecta awarded position on $700 million Multiple Award Blanket Purchase Agreement with DHS to provide national security investigations

Tuesday, May 4, 2021 - 11:00pm

"Our team has an enduring commitment to provide top quality investigations across all case types and helps agencies like DHS verify the trustworthiness of their employees to ensure continuity in fulfilling their missions.

Key Points: 
  • "Our team has an enduring commitment to provide top quality investigations across all case types and helps agencies like DHS verify the trustworthiness of their employees to ensure continuity in fulfilling their missions.
  • "\nWith experienced field management teams and unparalleled quality control, Perspecta delivers integrity in employee onboarding, insider threat, compliance and risk management.\nAt Perspecta (NYSE: PRSP), we question, we seek and we solve.
  • Perspecta brings a diverse set of capabilities to our U.S. government customers in defense, intelligence, civilian, health care and state and local markets.
  • Our 280+ issued, licensed and pending patents are more than just pieces of paper, they tell the story of our innovation.

Stryker declares a $0.63 per share quarterly dividend

Tuesday, May 4, 2021 - 9:05pm

b'Kalamazoo, MI, May 04, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.63 per share payable July 30, 2021 to shareholders of record at the close of business on June 30, 2021, representing an increase of 9.6% versus the prior year and unchanged from the previous quarter.\nStryker is one of the world\xe2\x80\x99s leading medical technology companies and, together with its customers, is driven to make healthcare better.

Key Points: 
  • b'Kalamazoo, MI, May 04, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.63 per share payable July 30, 2021 to shareholders of record at the close of business on June 30, 2021, representing an increase of 9.6% versus the prior year and unchanged from the previous quarter.\nStryker is one of the world\xe2\x80\x99s leading medical technology companies and, together with its customers, is driven to make healthcare better.
  • The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.
  • More information is available at www.stryker.com .\nFor investor inquiries please contact:\nFor media inquiries please contact:\n'

Dallas Plastic Surgeon, William P. Adams Jr. MD, Named New President Of The Aesthetic Society

Monday, May 3, 2021 - 12:00pm

b'MIAMI BEACH, Fla., May 3, 2021 /PRNewswire/ -- The Aesthetic Society announced the election of William P. Adams Jr. MD, a plastic surgeon practicing in Dallas, TX as the new President of the 2,600-member organization dedicated to aesthetic plastic surgery.

Key Points: 
  • b'MIAMI BEACH, Fla., May 3, 2021 /PRNewswire/ -- The Aesthetic Society announced the election of William P. Adams Jr. MD, a plastic surgeon practicing in Dallas, TX as the new President of the 2,600-member organization dedicated to aesthetic plastic surgery.
  • Dr. Adams and his leadership team will focus on evidenced based aesthetic education and advancing the robust curriculum The Aesthetic Society provides for plastic surgeons.\n"It is an exceptional honor to assume the role of President of The Aesthetic Society.
  • Our members go above and beyond the standards of plastic surgeryadvancing the specialty while transforming lives," said William P. Adams Jr. MD, President of The Aesthetic Society.
  • The Aesthetic Society is at the forefront of innovation in aesthetic plastic surgery and cosmetic medicine globally.\n'

Overcoming the Treatment-Risk Paradox for Intensive Blood Pressure Care

Friday, April 30, 2021 - 3:14pm

b'Patients most likely to benefit from intensive systolic blood pressure treatment (SBP) versus standard treatment to reduce cardiovascular disease (CVD) may also be at risk for adverse events (AE).

Key Points: 
  • b'Patients most likely to benefit from intensive systolic blood pressure treatment (SBP) versus standard treatment to reduce cardiovascular disease (CVD) may also be at risk for adverse events (AE).
  • In an editorial discussing those risks and clinical decisions to pursue intensive care, Joseph Diamond, MD , of The Feinstein Institutes for Medical Research published an editorial in the Journal of American College of Cardiology (JACC).\nThis press release features multimedia.
  • View the full release here: https://www.businesswire.com/news/home/20210430005400/en/\nSBP treatment has been shown to prevent CVD events \xe2\x80\x93 such as acute coronary syndrome, stroke, heart failure and even death \xe2\x80\x93 in at-risk patients.
  • For more information about how we produce knowledge to cure disease, visit http://feinstein.northwell.edu and follow us on LinkedIn .\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210430005400/en/\n'

Encyclopedia of Virology, Edition No. 4 (2021) - ResearchAndMarkets.com

Thursday, April 29, 2021 - 9:08am

b'The "Encyclopedia of Virology.

Key Points: 
  • b'The "Encyclopedia of Virology.
  • Edition No.
  • 4" book from Elsevier Science and Technology has been added to ResearchAndMarkets.com\'s offering.\nEncyclopedia of Virology, Fourth Edition, builds on the solid foundation laid by the previous editions, expanding its reach with new and timely topics.
  • In five volumes, the work provides comprehensive coverage of the whole virosphere, making this a unique resource.\nContent explores viruses present in the environment and the pathogenic viruses of humans, animals, plants and microorganisms.

Melanoma Research Alliance Announces $8.1 million in Research Awards

Tuesday, April 27, 2021 - 3:30pm

b"The Melanoma Research Alliance, the largest non-profit funder of melanoma research, is proud to announce $8.1 million in funding for 34 new research awards.

Key Points: 
  • b"The Melanoma Research Alliance, the largest non-profit funder of melanoma research, is proud to announce $8.1 million in funding for 34 new research awards.
  • The awards, issued near the start of Melanoma Awareness Month, provide critical funding to address urgent unmet needs in melanoma.\n\xe2\x80\x9cCOVID-19 has impacted so much, including research and clinical trials.
  • This investment in melanoma research is needed now more than ever,\xe2\x80\x9d said MRA Board Chair and Co-Founder Debra Black.
  • As the largest nonprofit funder of melanoma research, it has dedicated over $131 million and leveraged an additional $415 million towards its mission.